Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life

por Monahan, R C, Beaart-van de Voorde, L J J, Steup-Beekman, G M, Magro-Checa, C, Huizinga, T W J, Hoekman, J, Kaptein, A A
Publicado 2017

Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort

por Magro-Checa, C., Kumar, S., Ramiro, S., Beaart-van de Voorde, L.J., Eikenboom, J., Ronen, I., de Bresser, J, van Buchem, M.A, Huizinga, T.W., Steup-Beekman, G.M.
Publicado 2018

Rheumatologists’ adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission

por Akdemir, G., Markusse, I.M., Goekoop-Ruiterman, Y.P.M., Steup-Beekman, G.M., Grillet, B.A.M., Kerstens, P.J.S.M., Lems, W.F., Huizinga, T.W.J., Allaart, C.F.
Publicado 2016

Complex medical history of a patient with a compound heterozygous mutation in C1QC

por Lubbers, R, Beaart-van de Voorde, L J J, van Leeuwen, K, de Boer, M, Gelderman, K A, van den Berg, M J, Ketel, A G, Simon, A, de Ree, J, Huizinga, T W J, Steup-Beekman, G M, Trouw, L A
Publicado 2019